Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
182 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06923826 | Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)(TROP2) | recruiting | Phase 2 | 32 | National University Hospital, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT03772561 | Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies(MEDIPAC) | recruiting | Phase 1 | 40 | National University Hospital, SingaporeOTHER |
| 1 |
| Jul 22, 2025 |
| clinicaltrials |
| NCT04986748 | Using QPOP to Predict Treatment for Sarcomas and Melanomas | recruiting | — | 100 | National Cancer Centre, SingaporeOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT07019870 | Screening for Early Diagnosis of Nose Cancer | recruiting | N/A | 20,000 | National University Hospital, SingaporeOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT04687176 | Frontline Oral Arsenic Trioxide for APL | recruiting | Phase 2 | 100 | The University of Hong KongOTHER | 2 | Jun 12, 2025 | clinicaltrials |
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | recruiting | — | 600 | National Cancer Centre, SingaporeOTHER | 3 | Jun 12, 2025 | clinicaltrials |
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | recruiting | — | 5,000 | National Cancer Centre, SingaporeOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06073106 | Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention(OPTIMA-C) | recruiting | — | 500 | Tan Tock Seng HospitalOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT04775485 | A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors(FIREFLY-1) | recruiting | Phase 2 | 141 | Day One Biopharmaceuticals, Inc.INDUSTRY | 11 | Apr 10, 2025 | clinicaltrials |
| NCT05687747 | Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma | recruiting | Phase 1 | 100 | National University Hospital, SingaporeOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT05417932 | A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma(TCR-T) | recruiting | Phase 1 / Phase 2 | 46 | SCG Cell Therapy Pte. Ltd.INDUSTRY | 3 | Feb 18, 2025 | clinicaltrials |
| NCT06528184 | Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings | recruiting | N/A | 650 | National Healthcare Group PolyclinicsOTHER_GOV | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06422403 | A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers(VALUE-CHECK) | recruiting | Phase 2 | 360 | National University Hospital, SingaporeOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06744764 | Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization(PEMF) | recruiting | N/A | 76 | National University Hospital, SingaporeOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06733948 | ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients | recruiting | Phase 2 | 50 | National University Hospital, SingaporeOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT03394417 | StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients | recruiting | N/A | 100 | National University Hospital, SingaporeOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT06645691 | Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body(POLARIC-13) | recruiting | Phase 2 | 200 | National Heart Centre SingaporeOTHER | 1 | Dec 6, 2024 | clinicaltrials |
| NCT06172595 | FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma(FET PET in HGG) | recruiting | Phase 2 | 22 | Singapore General HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT05302037 | Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)(ANGELICA) | recruiting | Phase 1 | 12 | CytoMed Therapeutics Pte LtdINDUSTRY | 1 | Nov 22, 2024 | clinicaltrials |
| NCT06676761 | Outcomes of a Novel Technique Minimal Scar Mastectomy | recruiting | — | 100 | KK Women's and Children's HospitalOTHER_GOV | 1 | Nov 6, 2024 | clinicaltrials |
| NCT05517135 | tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella) | recruiting | — | 1,000 | National Cancer Centre, SingaporeOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06491056 | Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)(ProAMFocal) | recruiting | — | 500 | Singapore General HospitalOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT06336395 | Ma-Spore ALL 2020 Study | recruiting | Phase 2 | 500 | National University Hospital, SingaporeOTHER | 2 | Mar 28, 2024 | clinicaltrials |
| NCT06284031 | Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions | recruiting | N/A | 56 | National University Hospital, SingaporeOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06259513 | Omission of Axillary Surgery in Breast Cancer Patients | recruiting | N/A | 350 | KK Women's and Children's HospitalOTHER_GOV | 1 | Feb 14, 2024 | clinicaltrials |
| NCT04745403 | Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)(SAFE-T-HBV) | recruiting | Phase 1 | 10 | Lion TCR Pte. Ltd.INDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT05648019 | CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol | recruiting | Phase 2 | 40 | KK Women's and Children's HospitalOTHER_GOV | 1 | Mar 9, 2023 | clinicaltrials |
| NCT05363657 | International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors(i-RECORd) | recruiting | — | 10,000 | Azienda Ospedaliero-Universitaria CareggiOTHER | 13 | May 6, 2022 | clinicaltrials |
| NCT05043571 | CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia | recruiting | Phase 1 | 20 | National University Hospital, SingaporeOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT04960839 | Prophylactic Irradiation to the Contralateral Breast for BCAs Patients(PICB) | recruiting | N/A | 323 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 2 | Jul 14, 2021 | clinicaltrials |
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | recruiting | Phase 3 | 508 | Sun Yat-sen UniversityOTHER | 2 | Sep 28, 2020 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials